Spatiotemporal Gene Regulation and KSHV Replication

时空基因调控和 KSHV 复制

基本信息

  • 批准号:
    10436841
  • 负责人:
  • 金额:
    $ 35.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-07-01 至 2023-06-30
  • 项目状态:
    已结题

项目摘要

Kaposi's sarcoma-associated herpesvirus (KSHV) genomic episomes dynamically move in three- dimensional (3D) nuclear space to ultimately aggregate in reactivating cells. Cellular RNA polymerase II (RNA pol II) also translocates onto the aggregated viral genomes, resulting in the formation of viral transcriptional factories. This previously uncharacterized mechanism represents an additional layer of KSHV gene regulation, which facilitates the reutilization and repurposing of the limited quantities of cellular RNA pol II for effective viral gene expression. Understanding this mechanism may allow us to identify new targets to inhibit viral replication. In this application, we propose a comprehensive study to (1) identify the key cellular proteins involved with viral transcriptional factory structure or function; (2) determine the role of noncoding PAN RNA transcripts and its genomic region in viral transcriptional factory formation; and (3) visualize the physical assembly of viral transcriptional factories in the nuclei of reactivated host cells using live 3D fluorescence microscopy. We will also characterize the molecular architecture of viral transcriptional factories by super-resolution optical microscopy with correlative electron microscopic imaging. Through this multifaceted approach, we hope to understand the role of viral transcriptional factories in the amplification of KSHV gene expression, which may in turn lead to the development of new therapeutic strategies for KSHV-associated malignancies by inhibiting viral replication. In addition, we expect this investigation will shed light on the spatio-temporal (4D) organization of the cell nucleome: using KSHV as a well-defined model chromosome that we can readily track in the host cell nucleus with biochemical and genetic approaches.
卡波西肉瘤相关疱疹病毒(KSHV)基因组上游体在3个月内动态移动 三维(3D)核空间最终聚集在重新激活的细胞中。细胞RNA聚合酶II(RNA Pol II)也转位到聚集的病毒基因组上,导致形成病毒转录 工厂。这一以前未被描述的机制代表了KSHV基因调控的额外一层, 它促进了有限数量的细胞RNA polII的再利用和再利用,以获得有效的病毒 基因表达。了解这一机制可能会让我们找到新的靶点来抑制病毒 复制。 在这一应用中,我们建议进行一项全面的研究,以(1)确定涉及的关键细胞蛋白 具有病毒转录工厂结构或功能;(2)确定非编码PAN RNA转录本的作用 及其基因组区域在病毒转录工厂的形成;以及(3)可视化病毒的物理组装 用实时3D荧光显微镜观察重新激活的宿主细胞的细胞核中的转录工厂。我们会 也用超分辨光学方法表征病毒转录工厂的分子结构 显微镜结合相关电子显微镜成像。通过这种多方面的方法,我们希望 了解病毒转录工厂在KSHV基因表达扩增中的作用,这可能在 转而通过抑制病毒来开发治疗KSHV相关恶性肿瘤的新策略 复制。此外,我们预计这项研究将有助于揭示时空(4D)组织 细胞核组:使用KSHV作为明确的模式染色体,我们可以很容易地在宿主细胞中追踪到它 用生物化学和遗传学的方法来研究细胞核。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yoshihiro Izumiya其他文献

Yoshihiro Izumiya的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yoshihiro Izumiya', 18)}}的其他基金

Studies on Epigenetically Active Latent Chromatin Maintenance
表观遗传活性潜在染色质维持的研究
  • 批准号:
    10570202
  • 财政年份:
    2022
  • 资助金额:
    $ 35.91万
  • 项目类别:
Development of Precision Analyses to Reveal "Hit&Run" Effects
开发精密分析以揭示“命中”
  • 批准号:
    10095754
  • 财政年份:
    2020
  • 资助金额:
    $ 35.91万
  • 项目类别:
Development of Precision Analyses to Reveal Hit&RunÃÂ Effects
开发精确分析以揭示命中
  • 批准号:
    10316988
  • 财政年份:
    2020
  • 资助金额:
    $ 35.91万
  • 项目类别:
Nano-Therapeutic Approaches for Oncogenic Herpesvirus-Mediated Malignancies
疱疹病毒介导的致癌性恶性肿瘤的纳米治疗方法
  • 批准号:
    9902205
  • 财政年份:
    2018
  • 资助金额:
    $ 35.91万
  • 项目类别:
Spatiotemporal Gene Regulation and KSHV Replication
时空基因调控和 KSHV 复制
  • 批准号:
    10203870
  • 财政年份:
    2018
  • 资助金额:
    $ 35.91万
  • 项目类别:
Nano-Therapeutic Approaches for Oncogenic Herpesvirus-Mediated Malignancies
疱疹病毒介导的致癌性恶性肿瘤的纳米治疗方法
  • 批准号:
    10437848
  • 财政年份:
    2018
  • 资助金额:
    $ 35.91万
  • 项目类别:
Nano-Therapeutic Approaches for Oncogenic Herpesvirus-Mediated Malignancies
疱疹病毒介导的致癌性恶性肿瘤的纳米治疗方法
  • 批准号:
    10203875
  • 财政年份:
    2018
  • 资助金额:
    $ 35.91万
  • 项目类别:
K-Rta as a Novel SUMO and Epigenetic Regulator
K-Rta 作为新型相扑和表观遗传调节剂
  • 批准号:
    8462230
  • 财政年份:
    2010
  • 资助金额:
    $ 35.91万
  • 项目类别:
K-Rta as a Novel SUMO and Epigenetic Regulator
K-Rta 作为新型相扑和表观遗传调节剂
  • 批准号:
    8096817
  • 财政年份:
    2010
  • 资助金额:
    $ 35.91万
  • 项目类别:
K-Rta as a Novel SUMO and Epigenetic Regulator
K-Rta 作为新型相扑和表观遗传调节剂
  • 批准号:
    8247666
  • 财政年份:
    2010
  • 资助金额:
    $ 35.91万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 35.91万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.91万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 35.91万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.91万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 35.91万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 35.91万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.91万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 35.91万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 35.91万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.91万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了